Govt pours $30m into CSL health research

21-07-2010

The Federal Government will allocate $30 million to increase Australia’s research and development capacity through CSL Limited.

This investment forms part of a $235 million project aimed at protecting Australians from disease.

The project will deliver a major expansion in R&D capacity at CSL Limited’s facility in Broadmeadows, Victoria.

It will help ensure that CSL can do medical research that will help save lives, provide lasting benefits to the community, and increase Australia’s readiness to tackle future health threats.

“CSL is a strategically important provider of vaccines, anti-venoms, blood products and diagnostic health products for the Australian community,” Innovation Minister Senator Kim Carr said.

“This investment will help build the infrastructure and develop the capabilities Australian scientists need to create complex, next-generation drugs and deal with future epidemic diseases,” he said.

“CSL plays a unique role in blood fractionation; the development of new vaccines, such as its first-to-market H1N1 vaccine; and the production of anti-venoms for bites that are only inflicted in Australia, for example from brown snakes and funnel-web spiders.

“Australia will benefit from this investment for years to come.”

RELATED NEWS

  1. Made a program change you wish you hadn't? Lose the only copy of the device program? Not sure if the program running is the right one?
    Control Logic’s ‘Vault’, powered by MDT AutoSave Change Management software, is a plug-and-play system to help reduce errors and downtime, increase productivity,...
  2. tank
    A collaborative partnership between Lockheed Martin, Australian manufacturer Omni Tanker and the University of New South Wales (UNSW) will look to develop and commercialise world-first composite tank technologies, thanks to a grant from the Federal Government’s Advanced Manufacturing Growth Centre...
  3. 3D printer
    Obsolescence is an unavoidable part of any manufacturing environment. However, it’s concerning that nearly 70% of companies admit they do not know when vital equipment requires replacing, or when they do, they scramble to find replacements. Here, Claudia Jarrett, country manager at automation parts...